Latest Nephrology Stories

EXTON, Penn., Feb. 5, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds the following key results, according to a recent BioTrends' report, ChartTrends: Bone and Mineral Metabolism in Chronic Kidney Disease - Non-Dialysis (CKD-ND) and Dialysis, which contains data from 962 EU5 dialysis patient charts and 928 EU5 CKD-ND patient charts: On average, nephrologists in the EU5 countries...

Product liability attorneys Mehr Law Group announced a new campaign to help consumers who believe they were injured as a result of their dialysis treatments. The firm is encouraging consumers who believe their injuries were the result of their dialysis treatment to call for a free consultation today. (PRWEB) February 03, 2013 The product liability attorneys Mehr Law Group announced a new campaign today to help consumers injured as a result of their dialysis treatment. Consumers who have...

The Rottenstein Law Group, a New York City-based product liability law firm, is representing plaintiffs from several states who allege that their loved ones died as a result of being treated with a product called GranuFlo or NaturaLyte. (PRWEB) February 01, 2013 The Rottenstein Law Group, a New York City-based product liability law firm, is representing plaintiffs from several states who allege that their loved ones died as a result of being treated with a product called GranuFlo or...

African Americans, individuals without private insurance less likely to receive a transplant before needing dialysis Highlights: African Americans and individuals without private health insurance are less likely to receive a kidney transplant before needing dialysis. Geographic region is not a major factor in determining whether a patient receives a kidney transplant before starting dialysis. Nearly 90,000 people in the U.S. are waiting for a kidney transplant, and many will die...

WINSTON-SALEM, N.C., Jan. 30, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced advances for its two lead programs, the Neo-Urinary Conduit(TM) and Neo-Kidney Augment(TM). "We look forward to successfully implanting the remaining three patients in the ongoing Phase 1 trial for the Neo-Urinary Conduit by the end of this quarter. Following the implantation of patient seven, we have begun to transfer the surgical procedure to...

LAWRENCE, Mass., Jan. 28, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, announced today that NxStage patient advocate Jim Smith, 64, of Indianola, Washington is beginning the first NxStage Home Hemodialysis Patient Awareness Tour of 2013 with a 4-week journey starting January 29th. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The Tour is designed to increase patient awareness of home...

NEW YORK, Jan. 28, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced successful top-line results from the long-term Phase 3 study of Zerenex(TM) (ferric citrate), the Company's ferric iron-based phosphate binder drug candidate, for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis. In this study, Zerenex met the study's primary endpoint, described below,...

NEW YORK, Jan. 27, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) will host a conference call tomorrow, Monday, January 28, at 8:00am ET to review the top-line results from the Phase 3 long-term study component of its Phase 3 registration program of Zerenex((TM)) (ferric citrate), the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis. Keryx...

LawsuitLegal.com is now offering free legal evaluations to victims nationwide who have suffered complications following dialysis treatment. People who experienced health problems following treatment can share the details from their case and receive a legal review of their case. Ft. Lauderdale, FL (PRWEB) January 26, 2013 The nationwide trial legal service LawsuitLegal.com has announced that they are now offering free legal case reviews for people who died or suffered injury following a...

The Thompson Law Firm is reporting that plaintiffs have filed a motion to consolidate all federally-filed lawsuits involving dialysis concentrates GranuFlo and NaturaLyte. The firm continues to investigate claims on behalf of patients who suffered serious cardiac events during or shortly after dialysis. Columbus, OH (PRWEB) January 26, 2013 The Thompson Law Firm reports that plaintiffs have filed a motion to consolidate all federally-filed lawsuits involving GranuFlo and NaturaLyte, a...